FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ludwig Pichler

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Phenomena

Procedures

Preclinical Drug Evaluations

Concepts & Ideas

Drug Dose Response Relationship

Co-author Network

Publications

TOP 3
Eva-Maria Muchitsch; Ludwig Pichler; Hans Peter Schwarz
Effects of alpha1-acid glycoprotein in combination with catecholamines on hemorrhagic hypovolemic shock in rats.
Hans Peter Schwarz; Uwe Schlokat; Artur Mitterer; Katalin Váradi; Herbert Gritsch; Eva-Maria Muchitsch; Willfried Auer; Ludwig Pichler; Friedrich Dorner; Peter L Turecek
Recombinant von Willebrand factor-insight into structure and function through infusion studies in animals with severe von Willebrand disease.
Peter L Turecek; Katalin Váradi; Uwe Schlokat; Ludwig Pichler; Friedrich Dorner; Hans Peter Schwarz
In vivo and in vitro processing of recombinant pro-von Willebrand factor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ludwig Pichler (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Eva-Maria Muchitsch; Ludwig Pichler; Hans Peter Schwarz
Effects of alpha1-acid glycoprotein in combination with catecholamines on hemorrhagic hypovolemic shock in rats.
Arzneimittel-Forschung 2004;54(2):95-101.
2002: Hans Peter Schwarz; Uwe Schlokat; Artur Mitterer; Katalin Váradi; Herbert Gritsch; Eva-Maria Muchitsch; Willfried Auer; Ludwig Pichler; Friedrich Dorner; Peter L Turecek
Recombinant von Willebrand factor-insight into structure and function through infusion studies in animals with severe von Willebrand disease.
Seminars in thrombosis and hemostasis 2002;28(2):215-26.
2002: Peter L Turecek; Katalin Váradi; Uwe Schlokat; Ludwig Pichler; Friedrich Dorner; Hans Peter Schwarz
In vivo and in vitro processing of recombinant pro-von Willebrand factor.
Histochemistry and cell biology 2002;117(2):123-9.
2001: Barbara Plaimauer; Uwe Schlokat; Peter L Turecek; Artur Mitterer; Wolfgang Mundt; Willfried Auer; Ludwig Pichler; Herbert Gritsch; Hans Peter Schwarz
Recombinant von Willebrand factor: preclinical development.
Seminars in thrombosis and hemostasis 2001;27(4):395-403.
2000: Eva-Maria Muchitsch; Katalin Varadi; Ludwig Pichler
Effects of alpha 1-acid glycoprotein on acute pancreatitis and acute lung injury in rats.
Arzneimittel-Forschung 2000;50(11):987-94.
1999: Eva-Maria Muchitsch; Peter L Turecek; K Zimmermann; Ludwig Pichler; Willfried Auer; G Richter; Herbert Gritsch; Hans Peter Schwarz
Phenotypic expression of murine hemophilia.
Thrombosis and haemostasis 1999;82(4):1371-3.
1999: Peter L Turecek; Ludwig Pichler; Willfried Auer; G Eder; Katalin Varadi; Artur Mitterer; Wolfgang Mundt; Uwe Schlokat; Friedrich Dorner; Ludovic Drouet; Jacqueline Roussi; Jan A van Mourik; Hans Peter Schwarz
Evidence for extracellular processing of pro-von Willebrand factor after infusion in animals with and without severe von Willebrand disease.
Blood 1999;94(5):1637-47.
1999: Ludwig Pichler; Eva-Maria Muchitsch; Hans Peter Schwarz
[Preclinical investigation of alpha 1-acid glycoprotein (orosomucoid)].
Wiener klinische Wochenschrift 1999;111(5):192-8.
1999: Hans Peter Schwarz; Friedrich Dorner; Artur Mitterer; Wolfgang Mundt; Uwe Schlokat; Ludwig Pichler; Peter L Turecek
Preclinical evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease.
Wiener klinische Wochenschrift 1999;111(5):181-91.
1999: Peter L Turecek; Katalin Varadi; Herbert Gritsch; Willfried Auer; Ludwig Pichler; G Eder; Hans Peter Schwarz
Factor Xa and prothrombin: mechanism of action of FEIBA.
Vox sanguinis 1999;77 Suppl 1():72-9.
1998: Hans Peter Schwarz; Friedrich Dorner; Artur Mitterer; Wolfgang Mundt; Uwe Schlokat; Ludwig Pichler; Peter L Turecek
Evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease.
Haemophilia : the official journal of the World Federation of Hemophilia 1998;4 Suppl 3():53-62.
1998: Eva-Maria Muchitsch; Willfried Auer; Ludwig Pichler
Effects of alpha 1-acid glycoprotein in different rodent models of shock.
Fundamental & clinical pharmacology 1998;12(2):173-81.
1997: Willfried Auer; Eva-Maria Muchitsch; A Philapitsch; Ludwig Pichler; Hans Peter Schwarz
Studies on the effect of human lys-plasminogen in a rat model of global cerebral ischemia.
Arzneimittel-Forschung 1997;47(11):1195-9.
1997: Peter L Turecek; Herbert Gritsch; Ludwig Pichler; Willfried Auer; B Fischer; Artur Mitterer; Wolfgang Mundt; Uwe Schlokat; Friedrich Dorner; Herm-Jan Brinkman; Jan A van Mourik; Hans Peter Schwarz
In vivo characterization of recombinant von Willebrand factor in dogs with von Willebrand disease.
Blood 1997;90(9):3555-67.
1997: Hans Peter Schwarz; Peter L Turecek; Ludwig Pichler; Artur Mitterer; Wolfgang Mundt; Friedrich Dorner; Jacqueline Roussi; Ludovic Drouet
Recombinant von Willebrand factor.
Thrombosis and haemostasis 1997;78(1):571-6.
1997: Peter L Turecek; Herbert Gritsch; G Richter; Willfried Auer; Ludwig Pichler; Hans Peter Schwarz
Assessment of bleeding for the evaluation of therapeutic preparations in small animal models of antibody-induced hemophilia and von Willebrand disease.
Thrombosis and haemostasis 1997;77(3):591-9.
1996: Eva-Maria Muchitsch; W Teschner; Y Linnau; Ludwig Pichler
In vivo effect of alpha 1-acid glycoprotein on experimentally enhanced capillary permeability in guinea-pig skin.
Archives internationales de pharmacodynamie et de thérapie 1996;331(3):313-21.
1995: Ludwig Pichler; W Schramm; W Ulrich; Katalin Varadi; Hans Peter Schwarz
Antinociceptive properties of protein C in a model of inflammatory hyperalgesia in rats.
Thrombosis and haemostasis 1995;73(2):252-5.
1990: Gerhard Stark; U Stark; M Decrinis; Andrea Obernosterer; Hans Peter Schwarz; A Philapitsch; Ludwig Pichler; Ernst Pilger
[Electrophysiologic effects of plasminogen activators and plasmin].
VASA. Supplementum 1990;30():148-51.